Search Results

CVT 6883 5mg 5mg  | Purity Not Available

Adooq Bioscience

CVT-6883, a selective A2B adenosine antagonist, represents a novel potential approach to treating cardiopulmonary diseases.

More Information Supplier Page

CVT 6883 25mg 25mg  | Purity Not Available

Adooq Bioscience

CVT-6883, a selective A2B adenosine antagonist, represents a novel potential approach to treating cardiopulmonary diseases.

More Information Supplier Page

CVT 6883 10mg 10mg  | Purity Not Available

Adooq Bioscience

CVT-6883, a selective A2B adenosine antagonist, represents a novel potential approach to treating cardiopulmonary diseases.

More Information Supplier Page

CEP-28122 5mg 5mg  | Purity Not Available

Adooq Bioscience

CEP-28122 is a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.

More Information Supplier Page

CEP-28122 25mg 25mg  | Purity Not Available

Adooq Bioscience

CEP-28122 is a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.

More Information Supplier Page

Eprosartan mesylate 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Eprosartan (mesylate) is a competitive AT1 receptor antagonist with IC50 values ranging from 1.4 ?€? 3.9 nM and an elimination half-life of five to seven hours.

More Information Supplier Page

Eprosartan mesylate 250mg 250mg  | Purity Not Available

Adooq Bioscience

Eprosartan (mesylate) is a competitive AT1 receptor antagonist with IC50 values ranging from 1.4 ?€? 3.9 nM and an elimination half-life of five to seven hours.

More Information Supplier Page